The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27777011 |
92 |
Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases.![EBI](/images/logo_chembl.png) |
Depaul University |
24900651 |
50 |
Irreversible inhibitors of cysteine proteases.![EBI](/images/logo_chembl.png) |
Dart Neuroscience |
19715320 |
87 |
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.![EBI](/images/logo_chembl.png) |
University of Florida |
19908842 |
84 |
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.![EBI](/images/logo_chembl.png) |
National Human Genome Research Institute |
15686936 |
210 |
Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors.![EBI](/images/logo_chembl.png) |
Merck Frosst Centre For Therapeutic Research |
29648825 |
47 |
Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne.![EBI](/images/logo_chembl.png) |
Nestl� |
18307303 |
75 |
Discovery of selective aminothiazole aurora kinase inhibitors.![BDB](/images/logo_bindingdb.png) |
Novartis |
14698155 |
68 |
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3.![BDB](/images/logo_bindingdb.png) |
Bristol-Myers Squibb |